Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review
- PMID: 32816307
- PMCID: PMC9087651
- DOI: 10.1002/ijgo.13329
Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review
Abstract
Background: Pregnant women represent a potentially high-risk population in the COVID-19 pandemic.
Objective: To summarize clinical characteristics and outcomes among pregnant women hospitalized with COVID-19.
Search strategy: Relevant databases were searched up until May 29, 2020.
Selection criteria: Case series/reports of hospitalized pregnant women with laboratory-confirmed COVID-19.
Data collection and analysis: PRISMA guidelines were followed. Methodologic quality was assessed via NIH assessment tools.
Main results: Overall, 63 observational studies of 637 women (84.6% in third trimester) with laboratory-confirmed SARS-CoV-2 infection were included. Most (76.5%) women experienced mild disease. Maternal fatality, stillbirth, and neonatal fatality rates were 1.6%, 1.4%, and 1.0%, respectively. Older age, obesity, diabetes mellitus, and raised serum D-dimer and interleukin-6 were predictive of poor outcomes. Overall, 33.7% of live births were preterm, of which half were iatrogenic among women with mild COVID-19 and no complications. Most women underwent cesarean despite lacking a clear indication. Eight (2.0%) neonates had positive nasopharyngeal swabs after delivery and developed chest infection within 48 hours.
Conclusions: Advanced gestation, maternal age, obesity, diabetes mellitus, and a combination of elevated D-dimer and interleukin-6 levels are predictive of poor pregnancy outcomes in COVID-19. The rate of iatrogenic preterm birth and cesarean delivery is high; vertical transmission may be possible but has not been proved.
Keywords: COVID-19; Intrauterine fetal demise; Maternal morbidity; Maternal mortality; Miscarriage; Neonatal morbidity; Neonatal mortality; Preterm birth.
© 2020 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
Conflict of interest statement
The authors have no conflicts of interest.
Figures

References
-
- Johns Hopkins . Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed July 18, 2020.
-
- Moher D, Liberati A, Tetzlaff J, Altman DG; Group P . Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012. - PubMed
-
- Zhang L, Jiang Y, Wei M, et al. Analysis of the pregnancy outcomes in pregnant women with COVID‐19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi. 2020;55:166–171. - PubMed
-
- Zhou R, Chen Y, Lin C, et al. Asymptomatic COVID‐19 in pregnant woman with typical chest CT manifestation: A case report. Chinese. J Perinat Med. 2020;23.
-
- Li Y, J W, Jingjing Z,, et al. Asymptomatic novel coronavirus infection in pregnant woman in the third trimester: A case report. Chin J Perinat Med. 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous